<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04056624</url>
  </required_header>
  <id_info>
    <org_study_id>1R01HL142544-01A1</org_study_id>
    <nct_id>NCT04056624</nct_id>
  </id_info>
  <brief_title>Examining Validity and Sensitivity of Pressure-Mediated Reflection Spectroscopy</brief_title>
  <official_title>Examining Validity and Sensitivity of Pressure-Mediated Reflection Spectroscopy as a Measure of Fruit and Vegetable Consumption in a Diverse Community</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>East Carolina University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>East Carolina University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The central goal of this proposal is to examine validity and sensitivity of RS-assessed skin&#xD;
      carotenoid status as a marker of F&amp;V intake in a racially and ethnically diverse sample of&#xD;
      individuals. First, investigators will examine the association (RS Device Validity) between&#xD;
      RS-assessed skin carotenoids and the primary outcomes of objectively-measured plasma&#xD;
      carotenoids and self-reported F&amp;V consumption across four diverse groups:&#xD;
      African-American/Black, Asian, White, and Hispanic/Latino (n=213). Then the investigators&#xD;
      will conduct a randomized controlled trial to define the relative skin carotenoid responses&#xD;
      (RS Device Sensitivity) across racial-ethnic groups, in comparison with plasma carotenoid&#xD;
      responses. The investigators will conduct a 6-week randomized controlled trial of a&#xD;
      carotenoid-containing juice intervention [placebo control, low and high dose juice (N=156).&#xD;
      Finally, the genetic basis for racial/ethnic group differences in skin carotenoid responses&#xD;
      to diet will be investigated through hypothesis-driven genomic analysis of participants from&#xD;
      Aims 1 and 2.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A diet rich in fruits and vegetables (F&amp;Vs) is associated with lower risk of&#xD;
      nutrition-related chronic diseases and all-cause mortality. Despite these benefits, the US&#xD;
      population under-consumes F&amp;Vs, with particularly low intake in disadvantaged populations.&#xD;
      Low F&amp;V intake results in higher rates of nutrition-related chronic disease among&#xD;
      disadvantaged populations when compared with more advantaged populations. Detecting and&#xD;
      addressing inadequate F&amp;V intake in these populations is needed to reduce such disparities.&#xD;
      Yet, there is still no commonly used predictive, objective measure of F&amp;V intake for&#xD;
      surveillance or determination of policy or intervention effectiveness. The current objective,&#xD;
      &quot;gold standard&quot; marker of F&amp;V intake is blood carotenoid concentration-an expensive,&#xD;
      time-intensive, and invasive measurement. Traditional methods of self-reported dietary&#xD;
      assessment are imprecise and have diminished utility in rural and disadvantaged populations&#xD;
      due to low literacy, numeracy, and internet connectivity. In the past decade, skin carotenoid&#xD;
      status assessed by non-invasive resonance Raman spectroscopy (RRS) has emerged as a promising&#xD;
      biomarker of F&amp;V intake. Reflection spectroscopy (RS) is an improvement over RRS, offering&#xD;
      stronger signals, faster data acquisition, and greater portability in a commercially&#xD;
      available device (Veggie Meter, Longevity Link Corporation). However, a hurdle impedes use of&#xD;
      RS in scientific studies: to date, nearly all of the non-invasive skin carotenoid validation&#xD;
      has been conducted in non-Hispanic whites, primarily by RRS. Therefore, it is critical to&#xD;
      evaluate RS in racially and ethnically diverse populations. The central goal of this proposal&#xD;
      is to examine validity and sensitivity of RS-assessed skin carotenoid status as a marker of&#xD;
      F&amp;V intake in a racially and ethnically diverse sample of individuals. First, the&#xD;
      investigators will examine the association (RS Device Validity) between RS-assessed skin&#xD;
      carotenoids and the primary outcomes of objectively-measured plasma carotenoids and&#xD;
      self-reported F&amp;V consumption across four diverse groups: African-American/Black, Asian,&#xD;
      White, and Hispanic/Latino (target n = 320 but due to Covid-19, N=213). Then the&#xD;
      investigators will conduct a randomized controlled trial to define the relative skin&#xD;
      carotenoid responses (RS Device Sensitivity) across racial-ethnic groups, in comparison with&#xD;
      plasma carotenoid responses. The investigators will conduct an 6-week randomized controlled&#xD;
      trial of a carotenoid-containing juice intervention [placebo control, low and high dose juice&#xD;
      across 4 genetically-stratified racial-ethnic groups (goal n = 156). Finally, the genetic&#xD;
      basis for racial/ethnic group differences in skin carotenoid responses to diet will be&#xD;
      investigated through hypothesis-driven genomic analysis of participants from Aims 1 and 2.&#xD;
      The results of this study will prepare RS for mass deployment in population surveillance&#xD;
      studies and community-based intervention trials, ultimately leading to more accurate&#xD;
      determination of the most effective strategies to reduce health disparities related to low&#xD;
      F&amp;V intake in the United States and beyond.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 28, 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>First, investigators will examine the association (RS Device Validity) between RS-assessed skin carotenoids and the primary outcomes of objectively-measured plasma carotenoids and self-reported F&amp;V consumption across four diverse groups: African-American/Black, Asian, White, and Hispanic/Latino. Then investigators will conduct a randomized controlled trial to define the relative skin carotenoid responses (RS Device Sensitivity) across racial-ethnic groups, in comparison with plasma carotenoid responses. Investigators will conduct a 6-week randomized controlled trial of a carotenoid-containing juice intervention [placebo control, low and high dose juice across 4 genetically-stratified racial-ethnic groups (n = 156).</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin carotenoid status</measure>
    <time_frame>Change in skin carotenoid status from baseline to 3 weeks</time_frame>
    <description>Assessed using the Veggie Meter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin carotenoid status</measure>
    <time_frame>Change in skin carotenoid status from baseline to 6 weeks</time_frame>
    <description>Assessed using the Veggie Meter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma carotenoid status</measure>
    <time_frame>Change in plasma carotenoids from baseline to 3 weeks</time_frame>
    <description>Assessed using high performance liquid chromatography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma carotenoid status</measure>
    <time_frame>Change in plasma carotenoids from baseline to 6 weeks</time_frame>
    <description>Assessed using high performance liquid chromatography</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">156</enrollment>
  <condition>Dietary Habits</condition>
  <condition>Diet, Healthy</condition>
  <arm_group>
    <arm_group_label>Low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 x 6 ounces of carotenoid-containing juice (6 mg carotenoids/6 oz)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 x 6 ounces of carotenoid-containing juice (12 mg carotenoids/12 oz)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>12 ounces of apple juice (negligible carotenoids 0.06 mg/12 oz)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High carotenoid juice</intervention_name>
    <description>Juice with high carotenoids</description>
    <arm_group_label>High dose</arm_group_label>
    <arm_group_label>Low dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo control - Apple juice</intervention_name>
    <description>Juice with negligible carotenoids</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Self-identified as one of the racial/ethnic groups of focus&#xD;
&#xD;
          -  Read/speak English&#xD;
&#xD;
          -  Between 18 and 65 years of age&#xD;
&#xD;
          -  BMI 18.5-34.9 kg/m2&#xD;
&#xD;
          -  Non-pregnant&#xD;
&#xD;
          -  Non-lactating&#xD;
&#xD;
          -  Healthy (no chronic disease)&#xD;
&#xD;
          -  Not taking lipid-altering medication (medicines that lower cholesterol or&#xD;
             triglycerides)&#xD;
&#xD;
          -  Weight stable (have not gained or lost more than 15 pounds in the last 3 months).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not of one of the four racial/ethnic groups of focus&#xD;
&#xD;
          -  Not able to read/speak English&#xD;
&#xD;
          -  Under 18 years of age or over 65 years of age, do not&#xD;
&#xD;
          -  BMI less than 18.5 or more than 34.9 kg/m2&#xD;
&#xD;
          -  Pregnant (or have been pregnant in the last 6 weeks)&#xD;
&#xD;
          -  Lactating&#xD;
&#xD;
          -  High blood sugar ( â‰¥126 mg/dl)&#xD;
&#xD;
          -  Chronic disease such as cardiovascular disease, diabetes, chronic kidney disease,&#xD;
             diabetes cancer other than non-melanoma skin cancer (within the last 5 years), or&#xD;
             other weight-related chronic diseases.&#xD;
&#xD;
          -  Taking medication that lowers cholesterol or triglycerides Diagnosed with/ treated for&#xD;
             Crohn's disease.&#xD;
&#xD;
          -  Not weight stable (gained or lost more than 15 pounds in the last three months)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie B Jilcott Pitts, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>East Carolina University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stephanie B Jilcott Pitts, PhD</last_name>
    <phone>252-44-5572</phone>
    <email>jilcotts@ecu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Moe</last_name>
      <phone>612-626-8607</phone>
      <email>gerl0056@umn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Carolina University</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Pitts, PhD</last_name>
      <phone>252-744-5572</phone>
      <email>jilcotts@ecu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Gates, MPH</last_name>
      <phone>252-744-2952</phone>
      <email>gatese21@ecu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Moran, PhD</last_name>
      <phone>713-798-0520</phone>
      <email>Nancy.Moran@bcm.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jocelyn Chang</last_name>
      <email>Jocelyn.Chang@bcm.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 9, 2019</study_first_submitted>
  <study_first_submitted_qc>August 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2019</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>East Carolina University</investigator_affiliation>
    <investigator_full_name>Stephanie Pitts</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotenoids</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified data will be shared with other researchers.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will be available to share with other investigators 12 months after study completion.</ipd_time_frame>
    <ipd_access_criteria>Researchers must submit a plan for analysis, obtain Institutional Review Board approval and be approved by study investigators before data are released.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

